Isil Guney is a molecular biologist and co-founder of the Ulysses Advisory Group. She has been working with life science startups since 2014 to assist develop and bring promising technologies to the global market. She was formerly the Director of R&D at Bio Istanbul. Prior to that, she was a research associate at the Dana-Farber Cancer Institute, Harvard Medical School and the Broad Institute of Harvard and MIT, working to identify novel therapeutic targets for the treatment of advanced prostate cancer. Isil was a founding member and Board Director of MIT Enterprise Forum Turkey. She has a PhD from Brown University and is the author of numerous publications in high-impact, peer-reviewed journals.